Max Planck Innovation is responsible for technology transfer from the research institutes of the Max Planck Society, Germany's leading basic research organization.

We are partners of both science and industry:

We perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.

Technology offers

12.12.2017
Anti-mouse and anti-rabbit IgG secondary VHH single domain antibodies optimized for all immuno-labeling applications

Our technologies are as varied as the Max Planck Institutes themselves

all Technology offers

Latest news

06.11.2017
Max Planck Society grants license for protein analysis technique
ProteoPlex has exclusively licensed a technology from the Max Planck Institute for Biophysical ...

News alert

Do you want to receive our newsletter and press releases?
Subscribe here